Shares in niche pharmaceutical company Akorn (AKRX) are plunging 27% in Thursday’s pre trading on the news that the company has filed for …
Akorn, Inc. (NASDAQ:AKRX) investors are overwhelmingly excited today following an earlier report from Bloomberg, claiming that European health-care provider Kabi Fresenius is considering a bid …
Akorn, Inc. (NASDAQ:AKRX) announced that the U.
Akorn, Inc. (NASDAQ:AKRX) announced its financial results for the third quarter of 2016.
Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, today provided first quarter 2016 financial results.
Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, today announced that it has filed its Annual Report on Form 10-K for the fiscal …
Analysts are weighing in on drug maker Akorn, Inc. (NASDAQ:AKRX) and clothes maker G-III Apparel Group, Ltd.
Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, today provided preliminary unaudited 2015 financial results and issued 2016 financial guidance.
salesforce.com, inc.
Akorn, Inc. (NASDAQ:AKRX), a leading specialty generic pharmaceutical company, today announced that Gregory P.